Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 475.91M P/E - EPS this Y 146.20% Ern Qtrly Grth 376.80%
Income 3.32M Forward P/E 11.60 EPS next Y 62.50% 50D Avg Chg 6.00%
Sales 185.36M PEG - EPS past 5Y - 200D Avg Chg 32.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -18.00%
Recommedations 1.80 Quick Ratio 4.39 Shares Outstanding 36.21M 52W Low Chg 145.00%
Insider Own 24.86% ROA 18.14% Shares Float 16.73M Beta 0.87
Inst Own 45.10% ROE - Shares Shorted/Prior 1.03M/754.42K Price 6.73
Gross Margin 68.78% Profit Margin 1.79% Avg. Volume 152,087 Target Price 8.65
Oper. Margin 20.98% Earnings Date - Volume 55,106 Change -5.34%
About Biote Corp.

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Biote Corp. News
BTMD Chatroom

User Image Scientwist Posted - 2 days ago

$BTMD 📉 #BTMD Share Buyback! Biote is buying back 18.4M shares at $4.17, under the market rate. This reduces the float, potentially increasing share value. It's a strategic move post-litigation, aiming to enhance value. Be prepared for heightened volatility. This reflects confidence in their future, worth monitoring. #Investing #MarketMoves 📊

User Image Stock_Titan Posted - 04/29/24

$BTMD Biote Announces Definitive Settlement with Founder https://www.stocktitan.net/news/BTMD/biote-announces-definitive-settlement-with-d6m75zz6983f.html

User Image Stock_Titan Posted - 04/23/24

$BTMD Biote Schedules First Quarter 2024 Financial Results Release and Conference Call https://www.stocktitan.net/news/BTMD/biote-schedules-first-quarter-2024-financial-results-release-and-8j1gbcsm7vvo.html

User Image Bigbut Posted - 04/12/24

$BTMD yep $CVU yep $NKLA yep $WMT yep

User Image Doozio Posted - 4 weeks ago

$BTMD “buy the mother (fooking) dip”into poppa huckleberry then size up soon n ride in 🧠⏰? Let’s bang bro.

User Image MrBruceWayne Posted - 4 weeks ago

$BTMD 🚨load this hard n heavy for 100% profit

User Image Fullratio Posted - 03/16/24

$BTMD return on capital employed has surged by 151% YoY and by 4.5% QoQ: https://fullratio.com/stocks/nasdaq-btmd/biote

User Image Stockwatcher65 Posted - 03/15/24

$BTMD huge buy at close!

User Image Scientwist Posted - 03/13/24

$BTMD this was my favorite one.. 😂

User Image Scientwist Posted - 03/13/24

$BTMD This been my Sleeper… I am claiming this one!

User Image Stockwatcher65 Posted - 03/12/24

$BTMD

User Image DonCorleone77 Posted - 03/12/24

$BTMD Biote sees FY24 revenue $200M-$204M, consensus $203.17M Sees FY24 adjusted EBITDA $60M-$63M.

User Image DonCorleone77 Posted - 03/12/24

$BTMD Biote reports Q4 EPS 18c, consensus 8c Reports Q4 revenue $45.7M, consensus $45.74M. "Fourth quarter procedure revenue increased approximately 6.6%, reflecting stability for our hormone optimization therapies," said Terry Weber, Biote Chief Executive Officer. "Over the year, we also continued to expand our nationwide network, growing the net number of Biote-certified practitioners to more than 7,100."

User Image Stock_Titan Posted - 03/12/24

$BTMD Biote Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/BTMD/biote-reports-fourth-quarter-and-full-year-2023-financial-ojxm4rwfpeyx.html

User Image Stockwatcher65 Posted - 1 month ago

$BTMD that’s a whole lot of volume!!

User Image Stockwatcher65 Posted - 02/28/24

$BTMD

User Image Scientwist Posted - 02/28/24

$BTMD so under the radar… I love it! When it booms I’m ready!

User Image Stock_Titan Posted - 02/27/24

$BTMD Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call https://www.stocktitan.net/news/BTMD/biote-schedules-fourth-quarter-and-full-year-2023-financial-results-m1482jwlkbmf.html

User Image _StockTrader Posted - 02/27/24

Real-Time Stock Data $BTMD Price: 6.38 Volume: 61945 Market Cap: 457656608 PE Ratio: 16.128206 Stock data provided by: SDRC

User Image Bigbut Posted - 02/23/24

$BTMD yep

User Image Stockwatcher65 Posted - 02/23/24

$BTMD

User Image Stockwatcher65 Posted - 02/23/24

$BTMD

User Image Stockwatcher65 Posted - 02/22/24

$BTMD

User Image _StockTrader Posted - 02/21/24

Real-Time Stock Data $BTMD Price: 5.47 Volume: 180185 Market Cap: 388135008 PE Ratio: 17.208063 Stock data provided by: AITX

User Image Scientwist Posted - 02/21/24

🚀 $BTMD #BioteCorp embarks on a transformative journey with a strategic share repurchase, resolving litigation and signaling confidence in its undervalued stock. This pivotal move underlines the company's robust financial health, aims to boost EPS, and showcases a commitment to enhancing shareholder value during a period of strategic realignment. A testament to growth and innovation. #StockMarket 💼📈 My Sleeper!

User Image Stock_Titan Posted - 02/20/24

$BTMD Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares https://www.stocktitan.net/news/BTMD/biote-announces-agreement-to-resolve-litigation-and-repurchase-all-b2csmaq3uokk.html

User Image Scientwist Posted - 02/13/24

$BTMD 🚀 Exciting times for $BTMD as they announced a $20M share repurchase program, signaling strong confidence in their future! Finally people are reacting to it. With a robust balance sheet backing strategic moves, Biote is setting the stage to lead in therapeutic wellness. This proactive capital use showcases management's commitment to enhancing shareholder value. Keep an eye on $BTMD, as they're not just aiming for healthy aging solutions but also healthy investor returns! #Bullish #StockMarket 📈

User Image Scientwist Posted - 02/13/24

$BTMD finally. Now. Consolidate and own these levels please. 🙏

User Image _www_larval_com_ Posted - 02/12/24

$BTMD just shot 7% higher to 29% (~278Kv) in the last few minutes, follow for more volatility.

User Image VirmoMopire Posted - 01/30/24

$BTMD Keep an eye on this one. Could be something brewing. 🔍

Analyst Ratings
Roth MKM Buy Mar 13, 24
B. Riley Securities Buy Feb 20, 24
Jefferies Buy Feb 1, 24
Truist Securities Buy Jan 18, 24
Roth MKM Buy Jan 18, 24
TD Cowen Outperform Aug 15, 23
Roth MKM Buy Aug 14, 23
Roth MKM Buy Mar 30, 23
Truist Securities Buy Sep 27, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Conlon Mary Elizabeth General Counsel General Counsel Jul 05 Sell 6.5021 6,240 40,573 140,393 07/06/23
Conlon Mary Elizabeth General Counsel General Counsel Apr 04 Sell 5.9246 10,867 64,383 122,402 04/06/23
Roystone Capital Management LP 10% Owner 10% Owner Feb 07 Buy 3.25 375,000 1,218,750 2,971,566 02/17/23